Page last updated: 2024-10-27

fluorouracil and Papulosquamous Disorders

fluorouracil has been researched along with Papulosquamous Disorders in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hann, SK1
Rhoe, BS1
Kang, WH1
Park, YK1

Other Studies

1 other study available for fluorouracil and Papulosquamous Disorders

ArticleYear
Self limited dermal invasion of keratinocytes in maculopapular eruptions after systemic chemotherapy.
    The Journal of dermatology, 1993, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Breast Neoplasms; Carcinoma, Intr

1993